{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:34:53Z","timestamp":1791297293791,"version":"4.1.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"regional Junior Researcher Grant from the Sint Maartenskliniek, Nijmegen and the Radboud University Medical Centre, Nijmegen, the Netherlands.","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Twenty to thirty percent of psoriasis (Pso) patients will develop psoriatic arthritis (PsA). Detection of Pso patients that are (at risk for) developing PsA is essential to prevent structural damage. We conducted a systematic search of five bibliographic databases, up to May 2020. We searched for studies assessing markers (clinical, laboratory, genetic) associated with the development or presence of PsA in Pso patients. Study selection and quality assessment of the included studies was performed, followed by a qualitative best evidence synthesis to determine the level of evidence for a marker and its association with concomitant\/developing PsA in Pso. Overall, 259 possible markers were identified in 119 studies that met the inclusion criteria. Laboratory markers related to inflammation and bone metabolism reached a strong level of evidence for the association (not prediction) of PsA in Pso. Only CXCL10 showed strong evidence for a positive predictive value for PsA in Pso. The importance of timely detecting PsA in a Pso population, and finding more (bio)markers contributing to early detection, remains high.<\/jats:p>","DOI":"10.1186\/s13075-021-02545-4","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T10:03:03Z","timestamp":1623664983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5320-5702","authenticated-orcid":false,"given":"Michelle L. M.","family":"Mulder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara W.","family":"van Hal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Wenink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J. P. M.","family":"Koenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank H. J.","family":"van den Hoogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke M. G. J.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juul M. P. A.","family":"van den Reek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna E.","family":"Vriezekolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"issue":"5","key":"2545_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaci D, Behrens F, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729\u201335.","journal-title":"J Am Acad Dermatol."},{"issue":"12","key":"2545_CR2","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/rheumatology\/kex323","volume":"56","author":"W Tillett","year":"2017","unstructured":"Tillett W, Charlton R, Nightingale A, Snowball J, Green A, Smith C, et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatology (Oxford). 2017;56(12):2109\u201313.","journal-title":"Rheumatology (Oxford)."},{"issue":"12","key":"2545_CR3","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","volume":"42","author":"D Kane","year":"2003","unstructured":"Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford). 2003;42(12):1460\u20138.","journal-title":"Rheumatology (Oxford)."},{"issue":"6","key":"2545_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6\u2009months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045\u201350.","journal-title":"Ann Rheum Dis."},{"issue":"10012","key":"2545_CR5","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/S0140-6736(15)00347-5","volume":"386","author":"LC Coates","year":"2015","unstructured":"Coates LC, Moverley AR, McParland L, Brown S, Navarro-Coy N, O'Dwyer JL, et al. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet. 2015;386(10012):2489\u201398.","journal-title":"Lancet."},{"issue":"3","key":"2545_CR6","first-page":"469","volume":"27","author":"GH Ibrahim","year":"2009","unstructured":"Ibrahim GH, Buch MH, Lawson C, Waxman R, Helliwell PS. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol. 2009;27(3):469\u201374.","journal-title":"Clin Exp Rheumatol."},{"issue":"4","key":"2545_CR7","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/bjd.12190","volume":"168","author":"LC Coates","year":"2013","unstructured":"Coates LC, Aslam T, Al BF, Burden AD, Burden-Teh E, Caperon AR, et al. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol. 2013;168(4):802\u20137.","journal-title":"Br J Dermatol."},{"issue":"8","key":"2545_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/1744666X.2019.1627876","volume":"15","author":"MS Chimenti","year":"2019","unstructured":"Chimenti MS, Triggianese P, De Martino E, Conigliaro P, Fonti GL, Sunzini F, et al. An update on pathogenesis of psoriatic arthritis and potential therapeutic targets. Expert Rev Clin Immunol. 2019;15(8):823\u201336.","journal-title":"Expert Rev Clin Immunol."},{"issue":"2","key":"2545_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.berh.2018.09.006","volume":"32","author":"D Solmaz","year":"2018","unstructured":"Solmaz D, Eder L, Aydin SZ. Update on the epidemiology, risk factors, and disease outcomes of psoriatic arthritis. Best Pract Res Clin Rheumatol. 2018;32(2):295\u2013311. https:\/\/doi.org\/10.1016\/j.berh.2018.09.006.","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"3","key":"2545_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","volume":"15","author":"JU Scher","year":"2019","unstructured":"Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15(3):153\u201366.","journal-title":"Nat Rev Rheumatol."},{"issue":"4","key":"2545_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11926-020-0886-x","volume":"22","author":"S Rahmati","year":"2020","unstructured":"Rahmati S, Tsoi L, O'Rielly D, Chandran V, Rahman P. Complexities in genetics of psoriatic arthritis. Curr Rheumatol Rep. 2020;22(4):10.","journal-title":"Curr Rheumatol Rep."},{"issue":"Suppl 2","key":"2545_CR12","doi-asserted-by":"publisher","first-page":"ii104","DOI":"10.1136\/annrheumdis-2012-203037","volume":"72","author":"F Villanova","year":"2013","unstructured":"Villanova F, Di Meglio P, Nestle FO. Biomarkers in psoriasis and psoriatic arthritis. Ann Rheum Dis. 2013;72(Suppl 2):ii104\u201310.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"2545_CR13","doi-asserted-by":"publisher","first-page":"ii104","DOI":"10.1136\/annrheumdis-2012-203037","volume":"72","author":"F Villanova","year":"2013","unstructured":"Villanova F, Di MP, Nestle FO. Biomarkers in psoriasis and psoriatic arthritis. Ann Rheum Dis. 2013;72(Suppl 2):ii104\u2013i10.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2545_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1586\/1744666X.2016.1147954","volume":"12","author":"E Generali","year":"2016","unstructured":"Generali E, Scire CA, Favalli EG, Selmi C. Biomarkers in psoriatic arthritis: a systematic literature review. Expert Rev Clin Immunol. 2016;12(6):651\u201360. https:\/\/doi.org\/10.1586\/1744666X.2016.1147954.","journal-title":"Expert Rev Clin Immunol."},{"key":"2545_CR15","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647.","journal-title":"BMJ."},{"key":"2545_CR16","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis.\u00a0http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"2545_CR17","volume-title":"Evidence-based medicine: how to practice and reach EBM. 2nd edition ed","author":"DL Sackett","year":"2000","unstructured":"Sackett DL. Evidence-based medicine: how to practice and reach EBM. 2nd edition ed. New York: Churchill Livingstone; 2000."},{"issue":"4","key":"2545_CR18","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/art.39494","volume":"68","author":"L Eder","year":"2016","unstructured":"Eder L, Haddad A, Rosen CF, Lee KA, Chandran V, Cook R, et al. The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort Study. Arthritis Rheumatol. 2016;68(4):915\u201323.","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"2545_CR19","first-page":"757","volume":"29","author":"J Thumboo","year":"2002","unstructured":"Thumboo J, Uramoto K, Shbeeb MI, O'Fallon WM, Crowson CS, Gibson LE, et al. Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol. 2002;29(4):757\u201362.","journal-title":"J Rheumatol."},{"issue":"8","key":"2545_CR20","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/acr.20496","volume":"63","author":"L Eder","year":"2011","unstructured":"Eder L, Law T, Chandran V, Shanmugarajah S, Shen H, Rosen CF, et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken ). 2011;63(8):1091\u20137.","journal-title":"Arthritis Care Res (Hoboken )."},{"issue":"5","key":"2545_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/ard.2007.073932","volume":"67","author":"E Pattison","year":"2008","unstructured":"Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis. 2008;67(5):672\u20136. https:\/\/doi.org\/10.1136\/ard.2007.073932.","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"2545_CR22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/art.39973","volume":"69","author":"L Eder","year":"2017","unstructured":"Eder L, Polachek A, Rosen CF, Chandran V, Cook R, Gladman DD. The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study. Arthritis Rheumatol. 2017;69(3):622\u20139.","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"2545_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2340\/00015555-2912","volume":"98","author":"A Egeberg","year":"2018","unstructured":"Egeberg A, Skov L, Zachariae C, Gislason GH, Thyssen JP, Mallbris L. Duration of psoriatic skin disease as risk factor for subsequent onset of psoriatic arthritis. Acta Derm Venereol. 2018;98(6):546\u201350.","journal-title":"Acta Derm Venereol."},{"issue":"7","key":"2545_CR24","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archdermatol.2010.141","volume":"146","author":"R Soltani-Arabshahi","year":"2010","unstructured":"Soltani-Arabshahi R, Wong B, Feng BJ, Goldgar DE, Duffin KC, Krueger GG. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol. 2010;146(7):721\u20136.","journal-title":"Arch Dermatol."},{"issue":"2","key":"2545_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/art.24172","volume":"61","author":"FC Wilson","year":"2009","unstructured":"Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61(2):233\u20139. https:\/\/doi.org\/10.1002\/art.24172.","journal-title":"Arthritis Rheum."},{"key":"2545_CR26","doi-asserted-by":"publisher","unstructured":"Simon D, Tascilar K, Kleyer A, Bayat S, Kampylafka E, Sokolova M, et al. Structural entheseal lesions in patients with psoriasis are associated with an increased risk of progression to psoriatic arthritis. Arthritis Rheumatol. 2020.\u00a0 https:\/\/doi.org\/10.1002\/art.41239.","DOI":"10.1002\/art.41239"},{"issue":"12","key":"2545_CR27","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1002\/art.39800","volume":"68","author":"F Abji","year":"2016","unstructured":"Abji F, Pollock RA, Liang K, Chandran V, Gladman DD. Brief Report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis. Arthritis Rheumatol. 2016;68(12):2911\u20136.","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"2545_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/ard.2010.147793","volume":"71","author":"L Eder","year":"2012","unstructured":"Eder L, Shanmugarajah S, Thavaneswaran A, Chandran V, Rosen CF, Cook RJ, et al. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis. 2012;71(2):219\u201324.","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"2545_CR29","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/bjd.18227","volume":"182","author":"A Green","year":"2020","unstructured":"Green A, Shaddick G, Charlton R, Snowball J, Nightingale A, Smith C, et al. Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis. Br J Dermatol. 2020;182(3):714\u201320. https:\/\/doi.org\/10.1111\/bjd.18227.","journal-title":"Br J Dermatol."},{"issue":"5","key":"2545_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3899\/jrheum.140808","volume":"42","author":"S Wu","year":"2015","unstructured":"Wu S, Cho E, Li WQ, Han J, Qureshi AA. Alcohol intake and risk of incident psoriatic arthritis in women. J Rheumatol. 2015;42(5):835\u201340.","journal-title":"J Rheumatol."},{"issue":"1","key":"2545_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/annrheumdis-2017-211625","volume":"77","author":"UDT Nguyen","year":"2018","unstructured":"Nguyen UDT, Zhang Y, Lu N, Louie-Gao Q, Niu J, Ogdie A, et al. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study. Ann Rheum Dis. 2018;77(1):119\u201323. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211625.","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"2545_CR32","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/annrheumdis-2011-200416","volume":"71","author":"W Li","year":"2012","unstructured":"Li W, Han J, Qureshi AA. Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71(6):804\u20138.","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"2545_CR33","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","volume":"71","author":"TJ Love","year":"2012","unstructured":"Love TJ, Zhu Y, Zhang Y, Wall-Burns L, Ogdie A, Gelfand JM, et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis. 2012;71(8):1273\u20137.","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"2545_CR34","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1136\/annrheumdis-2011-201273","volume":"71","author":"W Li","year":"2012","unstructured":"Li W, Han J, Qureshi AA. Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71(8):1267\u201372. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201273.","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"2545_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/annrheumdis-2016-209334","volume":"76","author":"SM Thorarensen","year":"2017","unstructured":"Thorarensen SM, Lu N, Ogdie A, Gelfand JM, Choi HK, Love TJ. Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2017;76(3):521\u20135. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209334.","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"2545_CR36","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jid.2016.11.032","volume":"137","author":"RT Lewinson","year":"2017","unstructured":"Lewinson RT, Vallerand IA, Lowerison MW, Parsons LM, Frolkis AD, Kaplan GG, et al. Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: a population-based study. J Invest Dermatol. 2017;137(4):828\u201335. https:\/\/doi.org\/10.1016\/j.jid.2016.11.032.","journal-title":"J Invest Dermatol."},{"key":"2545_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1756-0500-2-44","volume":"2","author":"NS Abdel Fattah","year":"2009","unstructured":"Abdel Fattah NS, Hassan HE, Galal ZA, El Okdael SE. Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis. BMC Res Notes. 2009;2:44.","journal-title":"BMC Res Notes"},{"issue":"5","key":"2545_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/rhu.0000242779.73390.51","volume":"12","author":"L Candia","year":"2006","unstructured":"Candia L, Marquez J, Gonzalez C, Santos AM, Londono J, Valle R, et al. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis. J Clin Rheumatol. 2006;12(5):226\u20139.","journal-title":"J Clin Rheumatol."},{"issue":"3","key":"2545_CR39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/ard.2005.040998","volume":"65","author":"GM Alenius","year":"2006","unstructured":"Alenius GM, Berglin E, Rantapaa DS. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis. 2006;65(3):398\u2013400. https:\/\/doi.org\/10.1136\/ard.2005.040998.","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"2545_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jdermsci.2008.06.008","volume":"53","author":"S Shibata","year":"2009","unstructured":"Shibata S, Tada Y, Komine M, Hattori N, Osame S, Kanda N, et al. Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis. J Dermatol Sci. 2009;53(1):34\u20139.","journal-title":"J Dermatol Sci."},{"key":"2545_CR41","doi-asserted-by":"publisher","first-page":"474028","DOI":"10.1155\/2013\/474028","volume":"2013","author":"S Dalmady","year":"2013","unstructured":"Dalmady S, Kiss M, Kepiro L, Kovacs L, Sonkodi G, Kemeny L, et al. Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris. Clin Dev Immunol. 2013;2013:474028.","journal-title":"Clin Dev Immunol."},{"issue":"6","key":"2545_CR42","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jaad.2013.08.007","volume":"69","author":"J Orgaz-Molina","year":"2013","unstructured":"Orgaz-Molina J, Magro-Checa C, Rosales-Alexander JL, Arrabal-Polo MA, Buendia-Eisman A, Raya-Alvarez E, et al. Association of 25-hydroxyvitamin D serum levels and metabolic parameters in psoriatic patients with and without arthritis. J Am Acad Dermatol. 2013;69(6):938\u201346.","journal-title":"J Am Acad Dermatol."},{"issue":"1","key":"2545_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3233\/BMR-169617","volume":"31","author":"MS Sag","year":"2018","unstructured":"Sag MS, Sag S, Tekeoglu I, Solak B, Kamanli A, Nas K, et al. Comparison of 25-hidroksi vitamin D serum concentrations in patients with psoriasis and psoriatic arthritis. J Back Musculoskelet Rehabil. 2018;31(1):37\u201343.","journal-title":"J Back Musculoskelet Rehabil."},{"issue":"6","key":"2545_CR44","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s10067-020-04959-y","volume":"39","author":"MM Esawy","year":"2020","unstructured":"Esawy MM, Makram WK, Albalat W, Shabana MA. Plasma gelsolin levels in patients with psoriatic arthritis: a possible novel marker. Clin Rheumatol. 2020;39(6):1881\u20138.","journal-title":"Clin Rheumatol."},{"issue":"3","key":"2545_CR45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2133.2011.10699.x","volume":"166","author":"P Gisondi","year":"2012","unstructured":"Gisondi P, Rossini M, Di Cesare A, Idolazzi L, Farina S, Beltrami G, et al. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol. 2012;166(3):505\u201310.","journal-title":"Br J Dermatol."},{"issue":"2","key":"2545_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00403-016-1709-9","volume":"309","author":"H Mysliwiec","year":"2017","unstructured":"Mysliwiec H, Baran A, Harasim-Symbor E, Choromanska B, Mysliwiec P, Milewska AJ, et al. Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients. Arch Dermatol Res. 2017;309(2):79\u201386.","journal-title":"Arch Dermatol Res."},{"issue":"4","key":"2545_CR47","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10067-007-0725-8","volume":"27","author":"P Borman","year":"2008","unstructured":"Borman P, Babaoglu S, Gur G, Bingol S, Bodur H. Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin Rheumatol. 2008;27(4):443\u20137.","journal-title":"Clin Rheumatol."},{"issue":"1","key":"2545_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF02208026","volume":"10","author":"G Hein","year":"1991","unstructured":"Hein G, Abendroth K, Muller A, Wessel G. Studies on psoriatic osteopathy. Clin Rheumatol. 1991;10(1):13\u20137.","journal-title":"Clin Rheumatol."},{"issue":"7","key":"2545_CR49","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/rheumatology\/keq105","volume":"49","author":"V Chandran","year":"2010","unstructured":"Chandran V, Cook RJ, Edwin J, Shen H, Pellett FJ, Shanmugarajah S, et al. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology (Oxford). 2010;49(7):1399\u2013405.","journal-title":"Rheumatology (Oxford)."},{"key":"2545_CR50","doi-asserted-by":"publisher","first-page":"194535","DOI":"10.1155\/2015\/194535","volume":"2015","author":"J Bartosinska","year":"2015","unstructured":"Bartosinska J, Michalak-Stoma A, Juszkiewicz-Borowiec M, Kowal M, Chodorowska G. The assessment of selected bone and cartilage biomarkers in psoriatic patients from Poland. Mediators Inflamm. 2015;2015:194535.","journal-title":"Mediators Inflamm."},{"key":"2545_CR51","doi-asserted-by":"publisher","unstructured":"Diani M, Perego S, Sansoni V, Bertino L, Gomarasca M, Faraldi M, et al. Differences in osteoimmunological biomarkers predictive of psoriatic arthritis among a large Italian cohort of psoriatic patients. Int J Mol Sci. 2019;20(22):5617. https:\/\/doi.org\/10.3390\/ijms20225617.","DOI":"10.3390\/ijms20225617"},{"issue":"1","key":"2545_CR52","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13075-017-1417-7","volume":"19","author":"DR Jadon","year":"2017","unstructured":"Jadon DR, Sengupta R, Nightingale A, Lu H, Dunphy J, Green A, et al. Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study. Arthritis Res Ther. 2017;19(1):210.","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"2545_CR53","doi-asserted-by":"publisher","first-page":"R164","DOI":"10.1186\/ar3123","volume":"12","author":"N Dalbeth","year":"2010","unstructured":"Dalbeth N, Pool B, Smith T, Callon KE, Lobo M, Taylor WJ, et al. Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. Arthritis Res Ther. 2010;12(4):R164.","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"2545_CR54","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/acr.23298","volume":"70","author":"D Cretu","year":"2018","unstructured":"Cretu D, Gao L, Liang K, Soosaipillai A, Diamandis EP, Chandran V. Differentiating psoriatic arthritis from psoriasis without psoriatic arthritis using novel serum biomarkers. Arthritis Care Res (Hoboken ). 2018;70(3):454\u201361.","journal-title":"Arthritis Care Res (Hoboken )."},{"issue":"1","key":"2545_CR55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1365-4632.2010.04600.x","volume":"50","author":"EA Attia","year":"2011","unstructured":"Attia EA, Khafagy A, Abdel-Raheem S, Fathi S, Saad AA. Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. Int J Dermatol. 2011;50(1):30\u20135.","journal-title":"Int J Dermatol."},{"issue":"1","key":"2545_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000471798","volume":"233","author":"J Li","year":"2017","unstructured":"Li J, Liu L, Rui W, Li X, Xuan D, Zheng S, et al. New interleukins in psoriasis and psoriatic arthritis patients: the possible roles of interleukin-33 to interleukin-38 in disease activities and bone erosions. Dermatology. 2017;233(1):37\u201346.","journal-title":"Dermatology."},{"issue":"5","key":"2545_CR57","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1111\/ijd.13159","volume":"55","author":"TE Amin","year":"2016","unstructured":"Amin TE, ElFar NN, Ghaly NR, Hekal MM, Hassan AM, Elsaadany HM. Serum level of receptor activator of nuclear factor kappa-B ligand in patients with psoriasis. Int J Dermatol. 2016;55(5):e227\u2013e33. https:\/\/doi.org\/10.1111\/ijd.13159.","journal-title":"Int J Dermatol."},{"issue":"3","key":"2545_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/ced.12251","volume":"39","author":"F Bos","year":"2014","unstructured":"Bos F, Capsoni F, Molteni S, Raeli L, Diani M, Altomare A, et al. Differential expression of interleukin-2 by anti-CD3-stimulated peripheral blood mononuclear cells in patients with psoriatic arthritis and patients with cutaneous psoriasis. Clin Exp Dermatol. 2014;39(3):385\u201390.","journal-title":"Clin Exp Dermatol."},{"issue":"5","key":"2545_CR59","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/ar4317","volume":"15","author":"H Benham","year":"2013","unstructured":"Benham H, Norris P, Goodall J, Wechalekar MD, FitzGerald O, Szentpetery A, et al. Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res Ther. 2013;15(5):R136.","journal-title":"Arthritis Res Ther."},{"key":"2545_CR60","doi-asserted-by":"publisher","unstructured":"Abji F, Lee KA, Pollock RA, Machhar R, Cook RJ, Chandran V, et al. Declining levels of serum chemokine (C-X-C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker? Br J Dermatol. 2020;183(5):920\u20137. https:\/\/doi.org\/10.1111\/bjd.18940.","DOI":"10.1111\/bjd.18940"},{"issue":"4","key":"2545_CR61","first-page":"413","volume":"14","author":"A Spadaro","year":"1996","unstructured":"Spadaro A, Taccari E, Riccieri V, Sensi F, Sili Scavalli A, Zoppini A. Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters. Clin Exp Rheumatol. 1996;14(4):413\u20136.","journal-title":"Clin Exp Rheumatol."},{"issue":"1","key":"2545_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5114\/ada.2018.78028","volume":"37","author":"A Pietrzak","year":"2020","unstructured":"Pietrzak A, Chabros P, Grywalska E, Pietrzak D, Kandzierski G, Wawrzycki BO, et al. Serum concentration of interleukin 6 is related to inflammation and dyslipidemia in patients with psoriasis. Postepy Dermatol Alergol. 2020;37(1):41\u20135.","journal-title":"Postepy Dermatol Alergol."},{"issue":"1","key":"2545_CR63","first-page":"120","volume":"27","author":"GM Alenius","year":"2009","unstructured":"Alenius GM, Eriksson C, Rantapaa DS. Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis? Clin Exp Rheumatol. 2009;27(1):120\u20133.","journal-title":"Clin Exp Rheumatol."},{"issue":"2","key":"2545_CR64","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/bjd.17700","volume":"181","author":"CM Johnson","year":"2019","unstructured":"Johnson CM, Fitch K, Merola JF, Han J, Qureshi AA, Li WQ. Plasma levels of tumour necrosis factor-alpha and adiponectin can differentiate patients with psoriatic arthritis from those with psoriasis. Br J Dermatol. 2019;181(2):379\u201380.","journal-title":"Br J Dermatol."},{"issue":"4","key":"2545_CR65","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5114\/ada.2018.77665","volume":"35","author":"M Pirowska","year":"2018","unstructured":"Pirowska M, Obtulowicz A, Lipko-Godlewska S, Gozdzialska A, Podolec K, Wojas-Pelc A. The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor alpha in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis. Postepy Dermatol Alergol. 2018;35(4):360\u20136. https:\/\/doi.org\/10.5114\/ada.2018.77665.","journal-title":"Postepy Dermatol Alergol."},{"issue":"9","key":"2545_CR66","first-page":"1021","volume":"100","author":"R Ausavarungnirun","year":"2017","unstructured":"Ausavarungnirun R, Intarasupht J, Nakakes A, Rojanametin K. Nail abnormalities, quality of life and serum inflammatory marker in psoriatic arthritis compare to psoriasis without arthritis. J Med Assoc Thailand. 2017;100(9):1021\u20136.","journal-title":"J Med Assoc Thailand."},{"issue":"1","key":"2545_CR67","doi-asserted-by":"publisher","first-page":"10870","DOI":"10.1038\/s41598-019-47310-5","volume":"9","author":"M Diani","year":"2019","unstructured":"Diani M, Casciano F, Marongiu L, Longhi M, Altomare A, Pigatto PD, et al. Increased frequency of activated CD8(+) T cell effectors in patients with psoriatic arthritis. Sci Rep. 2019;9(1):10870. https:\/\/doi.org\/10.1038\/s41598-019-47310-5.","journal-title":"Sci Rep."},{"issue":"3","key":"2545_CR68","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10067-009-1323-8","volume":"29","author":"F Canpolat","year":"2010","unstructured":"Canpolat F, Akpinar H, Eskioglu F. Mean platelet volume in psoriasis and psoriatic arthritis. Clin Rheumatol. 2010;29(3):325\u20138.","journal-title":"Clin Rheumatol."},{"issue":"2","key":"2545_CR69","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5114\/ada.2017.67076","volume":"34","author":"S Kilic","year":"2017","unstructured":"Kilic S, Resorlu H, Isik S, Oymak S, Akbal A, Hiz MM, et al. Association between mean platelet volume and disease severity in patients with psoriasis and psoriatic arthritis. Postepy Dermatol Alergol. 2017;34(2):126\u201330.","journal-title":"Postepy Dermatol Alergol."},{"issue":"3","key":"2545_CR70","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1346-8138.13061","volume":"43","author":"DS Kim","year":"2016","unstructured":"Kim DS, Shin D, Lee MS, Kim HJ, Kim DY, Kim SM, et al. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol. 2016;43(3):305\u201310. https:\/\/doi.org\/10.1111\/1346-8138.13061.","journal-title":"J Dermatol."},{"issue":"12","key":"2545_CR71","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1136\/annrheumdis-2012-202325","volume":"72","author":"L Eder","year":"2013","unstructured":"Eder L, Jayakar J, Pollock R, Pellett F, Thavaneswaran A, Chandran V, et al. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Ann Rheum Dis. 2013;72(12):1956\u201361.","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"2545_CR72","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/art.40499","volume":"70","author":"ME Husni","year":"2018","unstructured":"Husni ME, Wilson Tang WH, Lucke M, Chandrasekharan UM, Brennan DM, Hazen SL. Correlation of high-density lipoprotein-associated paraoxonase 1 activity with systemic inflammation, disease activity, and cardiovascular risk factors in psoriatic disease. Arthritis Rheumatol. 2018;70(8):1240\u201350. https:\/\/doi.org\/10.1002\/art.40499.","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"2545_CR73","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/acr.22144","volume":"66","author":"YC Lin","year":"2014","unstructured":"Lin YC, Dalal D, Churton S, Brennan DM, Korman NJ, Kim ES, et al. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis. Arthritis Care Res (Hoboken ). 2014;66(1):97\u2013103.","journal-title":"Arthritis Care Res (Hoboken )."},{"issue":"1","key":"2545_CR74","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1038\/s41598-019-39985-7","volume":"9","author":"M Krajewska-Wlodarczyk","year":"2019","unstructured":"Krajewska-Wlodarczyk M, Owczarczyk-Saczonek A, Placek W, Wojtkiewicz M, Wiktorowicz A, Wojtkiewicz J. Distal interphalangeal joint extensor tendon enthesopathy in patients with nail psoriasis. Sci Rep. 2019;9(1):3628.","journal-title":"Sci Rep."},{"key":"2545_CR75","doi-asserted-by":"publisher","unstructured":"Hur MS, Hong JY, Hong JR, Lee YW, Choe YB, Ahn KJ. Clinical characteristics of psoriatic patients with latent tuberculosis infection. Eur J Dermatol. 2020. https:\/\/doi.org\/10.1684\/ejd.2020.3757.","DOI":"10.1684\/ejd.2020.3757"},{"issue":"2","key":"2545_CR76","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5114\/aoms.2018.74021","volume":"15","author":"A Pietrzak","year":"2019","unstructured":"Pietrzak A, Chabros P, Grywalska E, Kicinski P, Pietrzak-Franciszkiewicz K, Krasowska D, et al. Serum lipid metabolism in psoriasis and psoriatic arthritis - an update. Arch Med Sci. 2019;15(2):369\u201375.","journal-title":"Arch Med Sci."},{"issue":"10","key":"2545_CR77","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s10067-019-04646-7","volume":"38","author":"A Ortolan","year":"2019","unstructured":"Ortolan A, Lorenzin M, Tadiotto G, Russo FP, Oliviero F, Felicetti M, et al. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients. Clin Rheumatol. 2019;38(10):2843\u201350.","journal-title":"Clin Rheumatol."},{"issue":"6","key":"2545_CR78","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/jdv.16203","volume":"34","author":"L Pasquali","year":"2020","unstructured":"Pasquali L, Svedbom A, Srivastava A, Rosen E, Lindqvist U, Stahle M, et al. Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis. J Eur Acad Dermatol Venereol. 2020;34(6):1248\u201356.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"2545_CR79","doi-asserted-by":"publisher","unstructured":"Lin SH, Ho JC, Li SC, Chen JF, Hsiao CC, Lee CH. MiR-146a-5p Expression in Peripheral CD14(+) Monocytes from Patients with Psoriatic Arthritis Induces Osteoclast Activation, Bone Resorption, and Correlates with Clinical Response. J Clin Med. 2019;8(1):110.\u00a0 https:\/\/doi.org\/10.3390\/jcm8010110.","DOI":"10.3390\/jcm8010110"},{"issue":"3","key":"2545_CR80","first-page":"486","volume":"36","author":"F Abji","year":"2018","unstructured":"Abji F, Pollock RA, Liang K, Chandran V, Gladman DD. Th17 gene expression in psoriatic arthritis synovial fluid and peripheral blood compared to osteoarthritis and cutaneous psoriasis. Clin Exp Rheumatol. 2018;36(3):486\u20139.","journal-title":"Clin Exp Rheumatol."},{"issue":"2","key":"2545_CR81","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/jid.2014.414","volume":"135","author":"RA Pollock","year":"2015","unstructured":"Pollock RA, Abji F, Liang K, Chandran V, Pellett FJ, Virtanen C, et al. Gene expression differences between psoriasis patients with and without inflammatory arthritis. J Invest Dermatol. 2015;135(2):620\u20133. https:\/\/doi.org\/10.1038\/jid.2014.414.","journal-title":"J Invest Dermatol."},{"key":"2545_CR82","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3389\/fimmu.2018.01936","volume":"9","author":"L Frasca","year":"2018","unstructured":"Frasca L, Palazzo R, Chimenti MS, Alivernini S, Tolusso B, Bui L, et al. Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: new biomarkers in PsA. Front Immunol. 2018;9:1936.","journal-title":"Front Immunol."},{"key":"2545_CR83","doi-asserted-by":"publisher","unstructured":"De Andrea M, De Santis M, Caneparo V, Generali E, Sirotti S, Isailovic N, et al. Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis. Clin Exp Immunol. 2020;199(1):88\u201396. https:\/\/doi.org\/10.1111\/cei.13376.","DOI":"10.1111\/cei.13376"},{"issue":"7","key":"2545_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101773","volume":"9","author":"H Maejima","year":"2014","unstructured":"Maejima H, Nagashio R, Yanagita K, Hamada Y, Amoh Y, Sato Y, et al. Moesin and stress-induced phosphoprotein-1 are possible sero-diagnostic markers of psoriasis. PLoS One. 2014;9(7):e101773. https:\/\/doi.org\/10.1371\/journal.pone.0101773.","journal-title":"PLoS One."},{"issue":"4","key":"2545_CR85","doi-asserted-by":"publisher","first-page":"562","DOI":"10.5507\/bp.2015.033","volume":"159","author":"M Husakova","year":"2015","unstructured":"Husakova M, Lippert J, Stolfa J, Sedova L, Arenberger P, Lacinova Z, et al. Elevated serum prolactin levels as a marker of inflammatory arthritis in psoriasis vulgaris. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(4):562\u20138.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub."},{"issue":"12","key":"2545_CR86","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/1346-8138.13968","volume":"44","author":"N Tsuruta","year":"2017","unstructured":"Tsuruta N, Imafuku S, Narisawa Y. Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients. J Dermatol. 2017;44(12):1349\u201352.","journal-title":"J Dermatol."},{"key":"2545_CR87","doi-asserted-by":"publisher","first-page":"1759720X1988074","DOI":"10.1177\/1759720X19880742","volume":"11","author":"N Barbarroja","year":"2019","unstructured":"Barbarroja N, Arias-de la Rosa I, Lopez-Medina C, Camacho-Sanchez MDR, Gomez-Garcia I, Velez-Garcia AJ, et al. Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis. Ther Adv Musculoskelet Dis. 2019;11:1759720X19880742.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"2545_CR88","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3906\/sag-1512-5","volume":"47","author":"E Yilmaz","year":"2017","unstructured":"Yilmaz E, Tamer E, Artuz F, Kulcu Cakmak S, Kokturk F. Evaluation of serum uric acid levels in psoriasis vulgaris. Turk J Med Sci. 2017;47(2):531\u20134. https:\/\/doi.org\/10.3906\/sag-1512-5.","journal-title":"Turk J Med Sci."},{"issue":"1","key":"2545_CR89","first-page":"442","volume":"28","author":"H Maejima","year":"2017","unstructured":"Maejima H, Kobayashi M, Yanagita K, Hamada Y, Nagashio R, Sato Y, et al. Valosin-containing protein is a possible sero-diagnostic marker of psoriatic arthritis. Biomed Res (India). 2017;28(1):442\u20136.","journal-title":"Biomed Res (India)."},{"issue":"9","key":"2545_CR90","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/exd.13727","volume":"27","author":"X Hong","year":"2018","unstructured":"Hong X, Jiang S, Marmolejo N, Vangipuram R, Ramos-Rojas E, Yuan Y, et al. Serum vascular endothelial growth factor receptor 3 as a potential biomarker in psoriasis. Exp Dermatol. 2018;27(9):1053\u20137.","journal-title":"Exp Dermatol."},{"issue":"7","key":"2545_CR91","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1468-3083.2012.04570.x","volume":"27","author":"P Jensen","year":"2013","unstructured":"Jensen P, Wiell C, Milting K, Poggenborg RP, Ostergaard M, Johansen JS, et al. Plasma YKL-40: a potential biomarker for psoriatic arthritis? J Eur Acad Dermatol Venereol. 2013;27(7):815\u20139.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"1","key":"2545_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1559-0275-12-1","volume":"12","author":"D Cretu","year":"2015","unstructured":"Cretu D, Liang K, Saraon P, Batruch I, Diamandis EP, Chandran V. Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers. Clin Proteomics. 2015;12(1):1. https:\/\/doi.org\/10.1186\/1559-0275-12-1.","journal-title":"Clin Proteomics."},{"issue":"1","key":"2545_CR93","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jocd.12994","volume":"19","author":"NH Abdelaal","year":"2020","unstructured":"Abdelaal NH, Elhefnawy NG, Abdulmonem SR, Sayed S, Saleh NA, Saleh MA. Evaluation of the expression of the stromal cell-derived factor-1 alpha (CXCL 12) in psoriatic patients after treatment with methotrexate. J Cosmet Dermatol. 2020;19(1):253\u20138.","journal-title":"J Cosmet Dermatol."},{"key":"2545_CR94","doi-asserted-by":"crossref","unstructured":"El-Leithy S, Sherif N, El-Arousy NH, El-Hilaly R, Shakweer MM. Cutaneous immunohistochemical expression of interleukin-23 receptor (IL-23R) in psoriasis and psoriatic arthritis patients: relation to musculoskeletal ultrasound findings. Egypt Rheumatol. 2020;42(4):313\u201318.","DOI":"10.1016\/j.ejr.2020.02.007"},{"issue":"6","key":"2545_CR95","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/art.40830","volume":"71","author":"Y Yuan","year":"2019","unstructured":"Yuan Y, Qiu J, Lin ZT, Li W, Haley C, Mui UN, et al. Identification of novel autoantibodies associated with psoriatic arthritis. Arthritis Rheumatol. 2019;71(6):941\u201351. https:\/\/doi.org\/10.1002\/art.40830.","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"2545_CR96","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1399-0039.1996.tb02687.x","volume":"48","author":"M Muto","year":"1996","unstructured":"Muto M, Date Y, Ichimiya M, Moriwaki Y, Mori K, Kamikawaji N, et al. Significance of antibodies to streptococcal M protein in psoriatic arthritis and their association with HLA-A*0207. Tissue Antigens. 1996;48(6):645\u201350.","journal-title":"Tissue Antigens."},{"issue":"4","key":"2545_CR97","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/art.33415","volume":"64","author":"R Winchester","year":"2012","unstructured":"Winchester R, Minevich G, Steshenko V, Kirby B, Kane D, Greenberg DA, et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum. 2012;64(4):1134\u201344.","journal-title":"Arthritis Rheum."},{"issue":"6","key":"2545_CR98","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1399-0039.2011.01670.x","volume":"77","author":"R Pollock","year":"2011","unstructured":"Pollock R, Chandran V, Barrett J, Eder L, Pellett F, Yao C, et al. Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. Tissue Antigens. 2011;77(6):554\u201361.","journal-title":"Tissue Antigens."},{"issue":"1","key":"2545_CR99","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/ard.2011.155044","volume":"71","author":"L Eder","year":"2012","unstructured":"Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen CF, Bull SB, et al. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2012;71(1):50\u20135. https:\/\/doi.org\/10.1136\/ard.2011.155044.","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"2545_CR100","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1136\/annrheumdis-2012-201308","volume":"71","author":"L Eder","year":"2012","unstructured":"Eder L, Chandran V, Pellett F, Shanmugarajah S, Rosen CF, Bull SB, et al. Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study. Ann Rheum Dis. 2012;71(8):1361\u20135. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201308.","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"2545_CR101","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00296-003-0325-0","volume":"24","author":"O Elkayam","year":"2004","unstructured":"Elkayam O, Segal R, Caspi D. Human leukocyte antigen distribution in Israeli patients with psoriatic arthritis. Rheumatol Int. 2004;24(2):93\u20137. https:\/\/doi.org\/10.1007\/s00296-003-0325-0.","journal-title":"Rheumatol Int."},{"key":"2545_CR102","doi-asserted-by":"publisher","unstructured":"Aterido A, Canete JD, Tornero J, Ferrandiz C, Pinto JA, Gratacos J, et al. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. Ann Rheum Dis. 2019;78(3):e214158. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214158.","DOI":"10.1136\/annrheumdis-2018-214158"},{"issue":"10","key":"2545_CR103","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/annrheumdis-2017-211414","volume":"76","author":"J Bowes","year":"2017","unstructured":"Bowes J, Ashcroft J, Dand N, Jalali-Najafabadi F, Bellou E, Ho P, et al. Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis. Ann Rheum Dis. 2017;76(10):1774\u20139.","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"2545_CR104","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/tan.12126","volume":"82","author":"RA Pollock","year":"2013","unstructured":"Pollock RA, Chandran V, Pellett FJ, Thavaneswaran A, Eder L, Barrett J, et al. The functional MICA-129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA-B and HLA-C. Tissue Antigens. 2013;82(1):43\u20137.","journal-title":"Tissue Antigens."},{"issue":"5","key":"2545_CR105","first-page":"891","volume":"35","author":"HT Liao","year":"2008","unstructured":"Liao HT, Lin KC, Chang YT, Chen CH, Liang TH, Chen WS, et al. Human leukocyte antigen and clinical and demographic characteristics in psoriatic arthritis and psoriasis in Chinese patients. J Rheumatol. 2008;35(5):891\u20135.","journal-title":"J Rheumatol."},{"issue":"2","key":"2545_CR106","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ajhg.2014.07.002","volume":"95","author":"Y Okada","year":"2014","unstructured":"Okada Y, Han B, Tsoi LC, Stuart PE, Ellinghaus E, Tejasvi T, et al. Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes. Am J Hum Genet. 2014;95(2):162\u201372.","journal-title":"Am J Hum Genet."},{"key":"2545_CR107","doi-asserted-by":"publisher","first-page":"1030256","DOI":"10.1155\/2019\/1030256","volume":"2019","author":"P Coto-Segura","year":"2019","unstructured":"Coto-Segura P, Coto E, Gonzalez-Lara L, Alonso B, Gomez J, Cuesta-Llavona E, et al. Gene variant in the NF-kappaB pathway inhibitor NFKBIA distinguishes patients with psoriatic arthritis within the spectrum of psoriatic disease. Biomed Res Int. 2019;2019:1030256.","journal-title":"Biomed Res Int."},{"issue":"5","key":"2545_CR108","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1136\/ard.2007.071399","volume":"67","author":"PY Ho","year":"2008","unstructured":"Ho PY, Barton A, Worthington J, Plant D, Griffiths CE, Young HS, et al. Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis. 2008;67(5):677\u201382.","journal-title":"Ann Rheum Dis."},{"issue":"5","key":"2545_CR109","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1684\/ejd.2013.2144","volume":"23","author":"T Cabaleiro","year":"2013","unstructured":"Cabaleiro T, Roman M, Gallo E, Ochoa D, Tudelilla F, Talegon M, et al. Association between psoriasis and polymorphisms in the TNF, IL12B, and IL23R genes in Spanish patients. Eur J Dermatol. 2013;23(5):640\u20135.","journal-title":"Eur J Dermatol."},{"issue":"20","key":"2545_CR110","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1093\/hmg\/dds295","volume":"21","author":"A Julia","year":"2012","unstructured":"Julia A, Tortosa R, Hernanz JM, Canete JD, Fonseca E, Ferrandiz C, et al. Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes. Hum Mol Genet. 2012;21(20):4549\u201357.","journal-title":"Hum Mol Genet."},{"issue":"2","key":"2545_CR111","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41(2):199\u2013204.","journal-title":"Nat Genet."},{"issue":"10","key":"2545_CR112","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1136\/annrheumdis-2014-207190","volume":"74","author":"A Julia","year":"2015","unstructured":"Julia A, Pinto JA, Gratacos J, Queiro R, Ferrandiz C, Fonseca E, et al. A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk. Ann Rheum Dis. 2015;74(10):1875\u201381.","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"2545_CR113","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cyto.2010.01.006","volume":"50","author":"J Soto-Sanchez","year":"2010","unstructured":"Soto-Sanchez J, Santos-Juanes J, Coto-Segura P, Coto E, Diaz M, Rodriguez I, et al. Genetic variation at the CCR5\/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis. Cytokine. 2010;50(2):114\u20136.","journal-title":"Cytokine."},{"issue":"5","key":"2545_CR114","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/bjd.12142","volume":"168","author":"Q Yang","year":"2013","unstructured":"Yang Q, Liu H, Qu L, Fu X, Yu Y, Yu G, et al. Investigation of 20 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in Chinese patients with psoriatic arthritis and psoriasis vulgaris. Br J Dermatol. 2013;168(5):1060\u20135.","journal-title":"Br J Dermatol."},{"issue":"2","key":"2545_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192010","volume":"13","author":"ND Loft","year":"2018","unstructured":"Loft ND, Skov L, Rasmussen MK, Gniadecki R, Dam TN, Brandslund I, et al. Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis. PLoS One. 2018;13(2):e0192010.","journal-title":"PLoS One."},{"issue":"9","key":"2545_CR116","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1136\/ard.2010.147421","volume":"70","author":"L Eder","year":"2011","unstructured":"Eder L, Chandran V, Pellett F, Pollock R, Shanmugarajah S, Rosen CF, et al. IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients. Ann Rheum Dis. 2011;70(9):1594\u20138.","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"2545_CR117","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/ard.2010.143123","volume":"70","author":"J Bowes","year":"2011","unstructured":"Bowes J, Eyre S, Flynn E, Ho P, Salah S, Warren RB, et al. Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Ann Rheum Dis. 2011;70(6):1016\u20139. https:\/\/doi.org\/10.1136\/ard.2010.143123.","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"2545_CR118","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jdermsci.2015.06.011","volume":"80","author":"A Batalla","year":"2015","unstructured":"Batalla A, Coto E, Gonzalez-Lara L, Gonzalez-Fernandez D, Gomez J, Aranguren TF, et al. Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and psoriasis in a Spanish cohort. J Dermatol Sci. 2015;80(2):111\u20135.","journal-title":"J Dermatol Sci."},{"issue":"7","key":"2545_CR119","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.humimm.2005.04.005","volume":"66","author":"F Williams","year":"2005","unstructured":"Williams F, Meenagh A, Sleator C, Cook D, Fernandez-Vina M, Bowcock AM, et al. Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol. 2005;66(7):836\u201341.","journal-title":"Hum Immunol."},{"issue":"6","key":"2545_CR120","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","volume":"97","author":"PE Stuart","year":"2015","unstructured":"Stuart PE, Nair RP, Tsoi LC, Tejasvi T, Das S, Kang HM, et al. Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture. Am J Hum Genet. 2015;97(6):816\u201336.","journal-title":"Am J Hum Genet."},{"issue":"10","key":"2545_CR121","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1136\/annrheumdis-2014-207187","volume":"74","author":"J Bowes","year":"2015","unstructured":"Bowes J, Loehr S, Budu-Aggrey A, Uebe S, Bruce IN, Feletar M, et al. PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus. Ann Rheum Dis. 2015;74(10):1882\u20135.","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"2545_CR122","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ejr.2016.02.005","volume":"38","author":"S Isik","year":"2016","unstructured":"Isik S, Silan F, Kilic S, Hiz MM, Ogretmen Z, Ozdemir O. 308G\/A and 238G\/A polymorphisms in the TNF-alpha gene may not contribute to the risk of arthritis among Turkish psoriatic patients. Egyptian Rheumatologist. 2016;38(4):313\u20137.","journal-title":"Egyptian Rheumatologist."},{"issue":"3","key":"2545_CR123","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/ard.61.3.213","volume":"61","author":"T Hohler","year":"2002","unstructured":"Hohler T, Grossmann S, Stradmann-Bellinghausen B, Kaluza W, Reuss E. de VK, et al. Differential association of polymorphisms in the TNFalpha region with psoriatic arthritis but not psoriasis. Ann Rheum Dis. 2002;61(3):213\u20138.","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"2545_CR124","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jdv.12071","volume":"28","author":"J Bostoen","year":"2014","unstructured":"Bostoen J, Van PL, Brochez L, Mielants H, Lambert J. A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis. J Eur Acad Dermatol Venereol. 2014;28(4):507\u201311. https:\/\/doi.org\/10.1111\/jdv.12071.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"6 Pt 1","key":"2545_CR125","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/S0190-9622(99)70078-2","volume":"40","author":"PG Calzavara-Pinton","year":"1999","unstructured":"Calzavara-Pinton PG, Franceschini F, Manera C, Zane C, Prati E, Cretti L, et al. Antiperinuclear factor in psoriatic arthropathy. J Am Acad Dermatol. 1999;40(6 Pt 1):910\u20133.","journal-title":"J Am Acad Dermatol."},{"issue":"5","key":"2545_CR126","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/annrheumdis-2012-201497","volume":"72","author":"L Eder","year":"2013","unstructured":"Eder L, Jayakar J, Shanmugarajah S, Thavaneswaran A, Pereira D, Chandran V, et al. The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone. Ann Rheum Dis. 2013;72(5):715\u201320.","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"2545_CR127","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/ijd.14646","volume":"59","author":"B Engin","year":"2020","unstructured":"Engin B, Tanakol A, Bulut H, Songur A, Vehid HE, Gokalp E, et al. Changes in serum TNF-like weak inducer of apoptosis (TWEAK) levels and Psoriasis Area Severity Index (PASI) scores in plaque psoriasis patients treated with conventional versus anti-TNF treatments. Int J Dermatol. 2020;59(2):207\u201315.","journal-title":"Int J Dermatol."},{"issue":"19","key":"2545_CR128","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003676","volume":"95","author":"X Li","year":"2016","unstructured":"Li X, Miao X, Wang H, Wang Y, Li F, Yang Q, et al. Association of serum uric acid levels in psoriasis: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(19):e3676.","journal-title":"Medicine (Baltimore)."},{"key":"2545_CR129","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2017.04.010","volume":"184","author":"A Mavropoulos","year":"2017","unstructured":"Mavropoulos A, Varna A, Zafiriou E, Liaskos C, Alexiou I, Roussaki-Schulze A, et al. IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNgamma-producing T cells. Clin Immunol. 2017;184:33\u201341. https:\/\/doi.org\/10.1016\/j.clim.2017.04.010.","journal-title":"Clin Immunol."},{"issue":"6","key":"2545_CR130","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.5114\/aoms.2019.89451","volume":"15","author":"H Mysliwiec","year":"2019","unstructured":"Mysliwiec H, Harasim-Symbor E, Baran A, Szterling-Jaworowska M, Milewska AJ, Chabowski A, et al. Abnormal serum fatty acid profile in psoriatic arthritis. Arch Med Sci. 2019;15(6):1407\u201314.","journal-title":"Arch Med Sci."},{"issue":"1","key":"2545_CR131","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejr.2016.05.008","volume":"39","author":"DA Farrag","year":"2017","unstructured":"Farrag DA, Asaad MK, Ghobrial CK. Evaluation of IL-34 in psoriasis and psoriatic arthritis patients: correlation with disease activity and severity. Egyptian Rheumatologist. 2017;39(1):25\u201331. https:\/\/doi.org\/10.1016\/j.ejr.2016.05.008.","journal-title":"Egyptian Rheumatologist."},{"issue":"5","key":"2545_CR132","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5114\/reum.2017.71627","volume":"55","author":"M Krajewska-Wlodarczyk","year":"2017","unstructured":"Krajewska-Wlodarczyk M, Owczarczyk-Saczonek A, Placek W. Changes in body composition and bone mineral density in postmenopausal women with psoriatic arthritis. Reumatologia. 2017;55(5):215\u201321.","journal-title":"Reumatologia."},{"issue":"6","key":"2545_CR133","doi-asserted-by":"publisher","first-page":"721","DOI":"10.17219\/acem\/78020","volume":"27","author":"J Bartosinska","year":"2018","unstructured":"Bartosinska J, Purkot J, Kowal M, Michalak-Stoma A, Krasowska D, Chodorowska G, et al. The expression of selected molecular markers of immune tolerance in psoriatic patients. Adv Clin Exp Med. 2018;27(6):721\u20135.","journal-title":"Adv Clin Exp Med."},{"issue":"3","key":"2545_CR134","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jdermsci.2014.05.010","volume":"75","author":"N Eiris","year":"2014","unstructured":"Eiris N, Gonzalez-Lara L, Santos-Juanes J, Queiro R, Coto E, Coto-Segura P. Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus. J Dermatol Sci. 2014;75(3):167\u201372. https:\/\/doi.org\/10.1016\/j.jdermsci.2014.05.010.","journal-title":"J Dermatol Sci."},{"issue":"3","key":"2545_CR135","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.sleep.2011.07.018","volume":"13","author":"YW Yang","year":"2012","unstructured":"Yang YW, Kang JH, Lin HC. Increased risk of psoriasis following obstructive sleep apnea: a longitudinal population-based study. Sleep Med. 2012;13(3):285\u20139.","journal-title":"Sleep Med."},{"issue":"2","key":"2545_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212043","volume":"14","author":"RA Pollock","year":"2019","unstructured":"Pollock RA, Zaman L, Chandran V, Gladman DD. Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis. PLoS One. 2019;14(2):e0212043. https:\/\/doi.org\/10.1371\/journal.pone.0212043.","journal-title":"PLoS One."},{"issue":"1","key":"2545_CR137","first-page":"69","volume":"11","author":"VM Voiculescu","year":"2018","unstructured":"Voiculescu VM, Solomon I, Popa A, Draghici CC, Dobre M, Giurcaneanu C, et al. Gene polymorphisms of TNF-238G\/A, TNF-308G\/A, IL10-1082G\/A, TNFAIP3, and MC4R and comorbidity occurrence in a Romanian population with psoriasis. J Med Life. 2018;11(1):69\u201374.","journal-title":"J Med Life."},{"issue":"4","key":"2545_CR138","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s13555-018-0266-x","volume":"8","author":"D Yan","year":"2018","unstructured":"Yan D, Ahn R, Leslie S, Liao W. Clinical and genetic risk factors associated with psoriatic arthritis among patients with psoriasis. Dermatol Ther (Heidelb). 2018;8(4):593\u2013604.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"1","key":"2545_CR139","first-page":"84","volume":"99","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Sun Y, Fu X, Wang Z, Yu G, Yue Z, et al. Identification of a single nucleotide polymorphism in NFKBIA with different effects on psoriatic arthritis and cutaneous psoriasis in China. Acta Derm Venereol. 2019;99(1):84\u20138.","journal-title":"Acta Derm Venereol."},{"issue":"10","key":"2545_CR140","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957\u201370.","journal-title":"N Engl J Med."},{"issue":"3","key":"2545_CR141","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1365-2249.2007.03377.x","volume":"148","author":"A Aggarwal","year":"2007","unstructured":"Aggarwal A, Agarwal S, Misra R. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10\/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA). Clin Exp Immunol. 2007;148(3):515\u20139.","journal-title":"Clin Exp Immunol."},{"issue":"8","key":"2545_CR142","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665\u201373. https:\/\/doi.org\/10.1002\/art.21972.","journal-title":"Arthritis Rheum."},{"key":"2545_CR143","doi-asserted-by":"publisher","unstructured":"Puig L. Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci. 2017;19(1):58. https:\/\/doi.org\/10.3390\/ijms19010058.","DOI":"10.3390\/ijms19010058"},{"issue":"9997","key":"2545_CR144","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Schon MP. Psoriasis. Lancet. 2015;386(9997):983\u201394. https:\/\/doi.org\/10.1016\/S0140-6736(14)61909-7.","journal-title":"Lancet."},{"issue":"4","key":"2545_CR145","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/bjd.16083","volume":"178","author":"L Chen","year":"2018","unstructured":"Chen L, Tsai TF. HLA-Cw6 and psoriasis. Br J Dermatol. 2018;178(4):854\u201362. https:\/\/doi.org\/10.1111\/bjd.16083.","journal-title":"Br J Dermatol."},{"key":"2545_CR146","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","volume":"33","author":"P Bowness","year":"2015","unstructured":"Bowness P. Hla-B27. Annu Rev Immunol. 2015;33:29\u201348.","journal-title":"Annu Rev Immunol."},{"issue":"4-5","key":"2545_CR147","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.autrev.2014.01.050","volume":"13","author":"E Suzuki","year":"2014","unstructured":"Suzuki E, Mellins ED, Gershwin ME, Nestle FO, Adamopoulos IE. The IL-23\/IL-17 axis in psoriatic arthritis. Autoimmun Rev. 2014;13(4-5):496\u2013502. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.050.","journal-title":"Autoimmun Rev."},{"issue":"36","key":"2545_CR148","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.3748\/wjg.v24.i36.4093","volume":"24","author":"I Aggeletopoulou","year":"2018","unstructured":"Aggeletopoulou I, Assimakopoulos SF, Konstantakis C, Triantos C. Interleukin 12\/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn\u2019s disease. World J Gastroenterol. 2018;24(36):4093\u2013103. https:\/\/doi.org\/10.3748\/wjg.v24.i36.4093.","journal-title":"World J Gastroenterol."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-021-02545-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T10:05:11Z","timestamp":1623665111000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-021-02545-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2545"],"URL":"https:\/\/doi.org\/10.1186\/s13075-021-02545-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"assertion":[{"value":"28 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MM: non-financial support from UCB, outside the submitted work; TvH: personal fees from Eli Lily, non-financial support from UCB, outside the submitted work; EdJ: research grants for the independent research fund of the department of dermatology of the Radboud University Medical Centre Nijmegen, the Netherlands from AbbVie, Pfizer, Novartis, Janssen Pharmaceutica, and Leo Pharma. Has acted as consultant and\/or paid speaker for and\/or participated in research sponsored by companies that manufacture drugs used for the treatment of psoriasis including AbbVie, Janssen Pharmaceutica, Novartis, Lily, Celgene, Leo Pharma, UCB, and Almirall. The other authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}